Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

548.75
-22.6350-3.96%
Volume:134.40K
Turnover:75.34M
Market Cap:23.54B
PE:19.63
High:577.02
Open:570.00
Low:547.63
Close:571.38
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.66
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.68
PE(LYR):19.70

Loading ...

United Therapeutics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

United Therapeutics CEO Martine Rothblatt Sells 9,500 Common Shares for $5.21 Million

Reuters
·
Jul 07

RBC Capital Raises United Therapeutics Price Target to $704 From $701, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

United Therapeutics CEO Martine Rothblatt Disposes of 8,500 Common Shares Worth $4.63 Million

Reuters
·
Jul 03

United Therapeutics Acquires Thymmune Therapeutics for USD 140 Million Upfront

Reuters
·
Jul 02

United Therapeutics Corp - Deal Valued at $140 Mln Cash Plus up to $160 Mln in Earn-outs by 2031

THOMSON REUTERS
·
Jul 02

14 Value Stocks of Companies Primed for Rapid Growth Through 2028

Dow Jones
·
Jul 02

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares Valued at $5.16 Million

Reuters
·
Jul 01

United Therapeutics IPF Opportunity Outweighs Base Business Risks, UBS Says

MT Newswires Live
·
Jul 01

United Therapeutics Shareholders Endorse 2026 Governance and Pay

TIPRANKS
·
Jun 30

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of 9,500 Common Shares for $5.12 Million

Reuters
·
Jun 30

United Therapeutics Shareholders Approve 2026 Stock Incentive Plan at Annual Meeting

Reuters
·
Jun 30

United Therapeutics Wins FDA Approval for Lungfx Lung Perfusion Device

Reuters
·
Jun 29

United Therapeutics Corp - Lung Bioengineering Expects to Add Lungfx to Services in 2027

THOMSON REUTERS
·
Jun 29

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29

United Therapeutics CEO Martine Rothblatt Disposes of USD 4.99 Million in Common Shares

Reuters
·
Jun 26

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of Common Shares Worth $5.08 Million

Reuters
·
Jun 24

United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million

Reuters
·
Jun 24

United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million

Reuters
·
Jun 23

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 5.19 million in common shares

Reuters
·
Jun 18